Today: 7 February 2026
Subscribe
Browse Category

Investing News 29 January 2026

Home Depot stock slips after 800 job cuts and full-time office order — what investors watch next

Home Depot stock slips after 800 job cuts and full-time office order — what investors watch next

Home Depot shares fell 0.8% to $372.43 Thursday after announcing about 800 corporate layoffs and a new five-day in-office policy. A Georgia WARN notice listed 797 affected employees, with layoffs starting March 31. Most cuts target technology roles. Investors await the company’s February 24 earnings release for updates on demand and margins.
29 January 2026
····
Analog Devices stock slips from a fresh high as AI spending jitters weigh on chip shares

Analog Devices stock slips from a fresh high as AI spending jitters weigh on chip shares

Analog Devices shares fell 0.5% to $316.17 Thursday, retreating after a 4.5% surge to a 52-week high the previous day. Chip stocks broadly slipped as investors questioned the pace of returns from heavy AI investments. Traders await Analog Devices’ Feb. 18 results for signals on demand. The iShares Semiconductor ETF dipped 0.7%, while Texas Instruments gained 0.9%.
29 January 2026
·····
Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals shares rose 5.8% to $25.99 Thursday afternoon, adding about $127 million in market value as broader indexes fell. Trading volume reached 926,000 shares. No new company news emerged, but traders are watching for Olema’s March update and progress on its late-stage palazestrant trial. The company reported over $500 million in cash and equivalents as of Dec. 31, 2025.
29 January 2026
·····
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
29 January 2026
·····
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
29 January 2026
········
RTX stock price holds near $200 after Pratt exec flags easing engine squeeze

RTX stock price holds near $200 after Pratt exec flags easing engine squeeze

RTX shares rose 0.3% to $199.98 Thursday, bucking a broader market decline. A Pratt & Whitney executive said the jet-engine supply shortage should ease by decade’s end. RTX reported Q4 revenue of $24.24 billion, up 12%, and forecast 2026 adjusted sales at up to $93 billion. Investors weighed engine repair updates, tariffs, and pressure on defense contractor payouts.
29 January 2026
·····
Abbott stock price steadies near a 52-week low as upgrade talk meets nutrition worries

Abbott stock price steadies near a 52-week low as upgrade talk meets nutrition worries

Abbott Laboratories shares rose 0.3% to $106.34 Thursday after a broker upgrade, following sharp losses from missed revenue and a cautious outlook last week. The stock touched a 52-week low of $105.27. Abbott plans to acquire Exact Sciences for $105 per share, with a shareholder vote set for Feb. 20. The company declared a $0.63 quarterly dividend, payable Feb. 13.
29 January 2026
·····
Humana stock bounces after Medicare Advantage rate shock; what traders are watching next

Humana stock bounces after Medicare Advantage rate shock; what traders are watching next

Humana shares rose 1.5% to $196.94 Thursday afternoon after steep losses earlier in the week, triggered by a U.S. proposal for a 0.09% Medicare Advantage payment hike in 2027. The stock had plunged 21% Tuesday and another 6.7% Wednesday. Investors await Humana’s quarterly results Feb. 11 and the final Medicare rate decision in April.
29 January 2026
····
Caterpillar stock price jumps after earnings beat, even as tariff bill swells

Caterpillar stock price jumps after earnings beat, even as tariff bill swells

Caterpillar shares rose about 3% to $662.81 after quarterly sales and adjusted profit beat estimates, driven by strong demand from data centers. Fourth-quarter sales reached $19.1 billion, up 18% year over year, while adjusted profit hit $5.16 per share. The company warned tariff-related costs could total $2.6 billion in 2026, with $800 million expected in Q1. Backlog climbed to $51 billion.
29 January 2026
····
IBM stock jumps today after earnings beat as investors weigh AI demand and Red Hat slowdown

IBM stock jumps today after earnings beat as investors weigh AI demand and Red Hat slowdown

IBM shares rose 3.9% to $305.65 Thursday after quarterly results beat estimates and the company reaffirmed its 2026 outlook. The gains stood out as software stocks broadly slumped, with SAP down over 16% and ServiceNow off 11%. IBM reported fourth-quarter revenue of $19.7 billion and announced a $1.68 dividend. Major indexes fell to their lowest in more than a week amid tech sector concerns.
29 January 2026
·····
Danaher stock slides again after outlook: what DHR investors are watching next

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher shares fell 2.2% to $219.49 Thursday after its 2026 profit outlook matched analyst estimates. Fourth-quarter revenue rose 4.5% to $6.8 billion, with adjusted earnings at $2.23 per share. CEO Rainer Blair said China diagnostics revenue declined only slightly in Q4, improving from previous quarters. Investors remain cautious as sector peers warn of continued weakness in academic research spending.
29 January 2026
·····
1 … 65 66 67 68 69 … 585

Stock Market Today

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

7 February 2026
Rio Tinto’s U.S. shares closed up 2.5% at $93.37 Friday after the company ruled out a merger with Glencore, triggering a six-month “no-bid” lockout under UK takeover rules. Both companies cited disagreements over valuation. Attention now turns to Rio’s Feb. 19 results and iron ore prices, which fell below $100 a tonne amid weak Chinese demand.
iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Go toTop